Jan 12, 2016, GTHP OTC Disclosure & News Service – Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today fourth quarter sales revenue for the LuViva® Advanced Cervical Scan was the highest since the launch of the product. LuViva product revenue was approximately $276,000 for the fourth quarter of 2015 versus approximately $183,000 for the same period of 2014, an increase of about 51%. Total sales forRead more
- BlackRidge Technology Helps Eliminate Fraud from Philanthropic Contributions with Jointly Developed Blockchain Application
- Millennium BlockChain Closes $5 Million Strategic Investment in BurstIQ
- Nutritional High Enters Canadian Cannabis Market With Partner Receiving Its Oil Extraction License
- Cannabis Strategic Ventures to Acquire Staffing Group With $1.5 Million in Revenue
- NASCAR Superstar Denny Hamlin Partners with Chanticleer Holdings to Open Little Big Burger Location in Cornelius, N.C.
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More